BARINTHUS BIOTHERAPEUTICS PLC — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D
$26M
D&A
$6M
Operating Income
$-71M
EBITDA
$-65M
Interest Expense
$51K
Interest Income
$2M
Other Income/Expense
$2M
Pretax Income
$-67M
Tax Provision
$-175K
Net Income
$-66M
Operating Margin
-454.1%
Net Margin
-408.0%
Effective Tax Rate
0.3%
Deferred Tax Assets
$7M
Deferred Tax Liabilities
$254K
DTA Valuation Allowance
$46M
Tax Credit Carryforwards
$313K
NOL Carryforwards
$160M
ETR (Continuing Operations)
0.3%
ETR Federal Statutory
25.0%
ETR Foreign Differential (pp)
1.2%
Operating Lease Cost
$3M
Revenue YoY Variation
-100.0%
Income YoY Variation
-3.8%